Abstract
Molecular breast imaging (MBI) using99mTc-sestamibi has advanced rapidly over the past decade. Technical advances allow lower-dose, higher-resolution imaging and biopsy capability. MBI can be used for supplemental breast cancer screening with mammography for women with dense breasts, as well as to assess neoadjuvant therapy response, evaluate disease extent, and predict breast cancer risk. This article highlights the current state of the art and future directions in MBI.
Original language | English (US) |
---|---|
Pages (from-to) | 17-21 |
Number of pages | 5 |
Journal | Journal of Nuclear Medicine |
Volume | 63 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2022 |
Keywords
- MBI
- breast specific g-imaging
- molecular breast imaging
- nuclear breast imaging
- sestamibi
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging